Medical Health & Life Science Research News

Recent research: EMEA's (Europe, Middle East and Africa) radiopharmaceuticals in nuclear medical market report in 2017

Recent research: EMEA's (Europe, Middle East and Africa) radiopharmaceuticals in nuclear medical market report in 2017

The study of the " Radiopharmaceuticals in Nuclear Medical Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.

- Advertising -

In this report, the EMEA Radiopharmaceuticals in Nuclear Medical market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medical for these regions, from 2012 to 2022 (forecast) 
Europe: Germany, France, UK, Russia, Italy and Benelux; 
Middle East: Saudi Arabia, Israel, UAE and Iran; 
Africa: South Africa, Nigeria, Egypt and Algeria.

- Advertising -

Request a sample of this report @ www.orbisresearch.com/contacts/request-sample/320697 .

EMEA Radiopharmaceuticals in Nuclear Medical market competition by top manufacturers/players, with Radiopharmaceuticals in Nuclear Medical sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including 
Bracco Imaging 
Cambridge Isotope Laboratories 
Cardinal Health 
Covidien 
Eczacibasi-Monrol 
Fujifilm Holdings Corporation 
GE Healthcare (Subsidiary Of General Electric Company) 
IBA Group 
Lantheus Medical Imaging 
Nordion 
Ntp Radioisotopes 
Siemens Healthcare 
Taiyo Nippon Sanso Corporation 
Urenco Limited 
Rotem Industries

Access a copy of EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medical Market visit @  www.orbisresearch.com/contact/purchase/320697     .

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into 
Diagnostic Radiopharmaceuticals 
Therapy Radiopharmaceuticals 
Enriched Stable Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Radiopharmaceuticals in Nuclear Medical for each application, including 
Diagnostic Application 
Therapeutic Application 
Research 
Pharmaceutical 
Industrial

Browse Complete Report @ www.orbisresearch.com/reports/inde…rket-report-2017 .

Some points from TOC:

Chapter One: Radiopharmaceuticals in Nuclear Medical Overview
1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medical
1.2 Classification of Radiopharmaceuticals in Nuclear Medical
1.2.1 EMEA Radiopharmaceuticals in Nuclear Medical Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Radiopharmaceuticals in Nuclear Medical Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Radiopharmaceuticals
1.2.4 Therapy Radiopharmaceuticals
1.2.5 Enriched Stable Isotopes
1.3 EMEA Radiopharmaceuticals in Nuclear Medical Market by Application/End Users
1.3.1 EMEA Radiopharmaceuticals in Nuclear Medical Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 EMEA Radiopharmaceuticals in Nuclear Medical Market by Region
1.4.1 EMEA Radiopharmaceuticals in Nuclear Medical Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Radiopharmaceuticals in Nuclear Medical (2012-2022)
1.5.1 EMEA Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate (2012-2022)
1.5.2 EMEA Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (2012-2022)

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...